Compare Eli Lilly And Co (LLY) vs Boston Beer Company Inc (SAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Boston Beer Company Inc — how do they compare? Eli Lilly And Co trades at $1,147.06 (market cap $1.02T), while Boston Beer Company Inc trades at $171.7 (market cap $1.88B). The key difference: Eli Lilly And Co is far larger — about 542.6× Boston Beer Company Inc's market cap, and Eli Lilly And Co pays a 0.6% dividend while Boston Beer Company Inc pays none. Which is the better fit depends on your goals.
| LLY | SAM | |
|---|---|---|
Market Cap | $1.02T | $1.88B |
Sector | Health | Consumer Staples |
52-Week High | $1.24K | $260.05 |
52-Week Low | $625.65 | $161.08 |
Enterprise Value | $1.06T | $1.75B |
Dividend Yield | 0.6% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Boston Beer Company (SAM) trades at $180.59, up 1.0% with a bullish technical signal from moving averages. The stock shows mixed fundamentals with a P/E of 22.66 and P/S of 0.99, but negative net income margin and ROE. Recent earnings beat expectations in Q3 and Q4 2025 but missed in Q1 2026. Analyst consensus is mixed with 74% hold ratings and a $204.33 price target, suggesting modest upside potential from current levels.
SAM faces near-term challenges including volume declines and competitive pressures in the hard seltzer segment, offset by strong cash flow generation and innovation in Beyond Beer categories. The company's improved gross margins and cost-saving initiatives provide some stability, but investor sentiment remains cautious ahead of Q2 earnings. The stock presents a balanced risk-reward profile with potential upside to analyst targets but requires monitoring of execution against guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Boston Beer Company Inc
Boston Beer is a leader in U.S. high-end malt beverages and adjacent categories, with strong positions in craft beer, hard cider, and hard seltzer. The firm sells an array of flavor variants and package sizes, predominantly centered around four priority brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly Hard Seltzer. Its drinks are produced in both company-owned breweries as well as through third-party contract arrangements, and while the company primarily goes to market through independent wholesalers (as mandated by law), it operates a fairly large salesforce to induce demand across the value chain (distributors, retailers, and drinkers). The preponderance of revenue is generated domestically.
Read more on SAM →
